Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Covid-19 vaccination indemnity cover of pharmacies extended until June 30

Vaccines deployment minister Nadhim Zahawi has extended the indemnity provided to the community pharmacies until June 30, 2021.

In a statement tabled in the parliament on Tuesday (Jan 19), the minister extended the indemnity provided to the community pharmacies further with an aim to push the Covid-19 vaccination drive in pharmacy sites and protect pharmacies with necessary indemnity cover.


The minister said in his statement: “Without adequate indemnity cover, pharmacies would be unable to commit to the programme. Their participation is crucial as they have been selected to fill geographical gaps in cover or where NHS capacity is such that they are unable to participate. Therefore, DHSC has provided a time limited clinical negligence indemnity to community pharmacy to June 30, 2021, to enable them to engage at pace with this programme.”

“The provision of such an indemnity enables pharmacy contractors to start to run services, whilst the Department and NHS England and Improvement continue to work with the community pharmacy sector on a longer-term approach to insuring community pharmacy for Covid-19 vaccinations.

“We had originally intended to time limit this to the end of March but with the decision to extend the period between vaccine doses, have decided to run the indemnity until the end of June.”

All claims of clinical negligence will be managed through the provider of the current state backed schemes – NHS Resolution - in line with the existing schemes.

The need for the indemnity was extremely urgent as pharmacy led centres could not begin to vaccinate patients until this was in place and indeed vaccinations have begun at six centres as of January 14, the minister said, adding, “delaying would have postponed the roll out of this vital aspect of the vaccination programme, restricting access to the vaccine in some areas of the county.

“We concluded that such a delay was not acceptable, and I hope it is clear why this was indeed a case of special urgency. Therefore, the normal 14 sitting days for consideration has on this occasion not been possible.”

The latest indemnity plan will cover clinical negligence, employer’s and public liability where a care provider seeking to become a ‘designated setting’ is unable to secure sufficient commercial insurance, or where an existing provider has been operating without sufficient cover.

More For You

Air pollution in UK linked to thousands of deaths and chronic health conditions

A report by the Royal College of Physicians claims that air pollution was causing harm to almost every organ of the body.

iStock

Royal College of Physicians paints grim picture of air pollution in UK

Doctors warn that around 99 per cent of the population in the UK are breathing "toxic air", and around 30,000 deaths will be linked to air pollution in 2025.

The Royal College of Physicians (RCP) claimed in a report that air pollution was causing harm to almost every organ of the body, and shortening life by 1.8 years on average.

Keep ReadingShow less
Community pharmacies falling behind on data security toolkit submissions

The last date for submission is 30 June 2025.

Pic credit: iStock

Community pharmacies falling behind on data security toolkit submissions

More than 50 per cent of the community pharmacies in England have failed to complete their Data Security and Protection Toolkit 2025 with the deadline in less than two weeks.

Necessary guidance regarding the toolkit has previously been provided by Community Pharmacy England (CPE) earlier.

Keep ReadingShow less
Digital guide launched to help patients with osteoporosis

In the UK, over three million people have osteoporosis.

Pic credit: iStock

Digital guide launched to help patients with osteoporosis

The Royal Osteoporosis Society (ROS) has launched a free online service called BoneMed which is aimed to support patients with osteoporosis in taking their medicine and remove barriers to adherence.

After completing a five-minute online survey, patients will be emailed a summary of the medicine they have been prescribed and six further updates throughout the year on their medication.

Keep ReadingShow less
GPhC five-year plan to empower pharmacists, uphold public trust

GPhC's Strategic Plan 2025-30 will focus on empowering pharmacists and pharmacy technicians.

iStock

GPhC five-year plan to empower pharmacists, uphold public trust

The General Pharmaceutical Council (GPhC) launched its new plan for the next five years to uphold safety, quality and public trust in pharmacy.

The regulatory body unveiled its Strategic Plan 2025-30 during a Parliamentary event attended by pharmacy minister Stephen Kinnock on Wednesday (18).

Keep ReadingShow less
Glucose monitor and test strips on a blood sugar tracker sheet with lancets and pen device.

Medical device manufacturers will have to monitor the safety and performance of their products already in use.

iStock

Medical device regulation overhauled to improve patients' safety

Medical device manufacturers must now adhere to the UK's post-market surveillance (PMS) regulations.

The new rule came into effect on June 16, and manufacturers will have to monitor the safety and performance of their products already in use.

Keep ReadingShow less